Clinical Trial Update: Safety and Efficacy Study of Human Umbilical Cord Mesenchymal Stem Cells in Preventing Arteriovenous Fistula Stenosis in Patients With End-Stage Diabetic Kidney Disease [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial evaluating whether human umbilical cord–derived mesenchymal stem cells can prevent arteriovenous fistula stenosis in patients with en…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Arteriovenous Fistula Stenosis
• Diabetic Nephropathy
• End-stage Renal Disease

Drugs mentioned

• Human Umbilical Cord Mesenchymal Stem Cells

Snippet

Sponsor: Jiangsu Topcel-KH Pharmaceutical Co., Ltd. | Conditions: Arteriovenous Fistula Stenosis | Phase 1, Phase 2 | Status: NOT_YET_RECRUITING